// App-Quantinova.ai

21663 : Costs Impact Rivaroxaban Plus Aspirin versus Aspirin in the COMPASS Trial

Researchers

Presenter

  • Andre Lamy

Principal Investigators

  • John Eikelboom

  • Stuart Connolly

  • Jackie Bosch

  • Keith A Fox

  • Wesley Tong

  • Fei Yuan

  • Salim Yusuf

Medical Centers

  • Cardiology Dept, Population Health Rsch Institute, Hamilton, Canada

  • Cardiology Dept, Population Health Rsch Institute, Hamilton, Canada

  • Cardiology Dept, Population Health Rsch Institute, Hamilton, Canada

  • Medicine, Univ of Edinburgh, Edinburgh, United Kingdom

  • Perioperative Sciences, Population Health Rsch Institute, Hamilton, Canada

  • Statistics, Population Health Rsch Institute, Hamilton, Canada

Locations

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved